SCHEMBL6090248

SCHEMBL6090248

CCC(O)(CC)c1ccc2[nH]cnc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.38
KDM4E B2RXH2 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
ALDH1A1 P00352 1/20 0.38
APEX1 P27695 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
MMP12 P39900 1/20 0.37
LCK P06239 1/20 0.36
TXK P42681 1/20 0.36
SYK P43405 1/20 0.36
ITK Q08881 1/20 0.36
PARP1 P09874 1/20 0.36
PIKFYVE Q9Y2I7 2/20 0.36
PRKCI P41743 1/20 0.36
PKM P14618 1/20 0.36
RAD52 P43351 1/20 0.35
P2RY14 Q15391 1/20 0.34
EPHX1 P07099 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2633081 0.83 MAPK1 (0.38) MAPTKDM4ETDP1ALDH1A1APEX1
SCHEMBL6750187 0.83 MAPT (0.40) MAPTKDM4ETDP1ALDH1A1APEX1
SCHEMBL762009 0.79 MAPT (0.42) MAPTKDM4ETDP1ALDH1A1APEX1
SCHEMBL22292145 0.78 MAPT (0.36) MAPTKDM4ETDP1ALDH1A1APEX1
SCHEMBL1265834 0.75 PARP1 (0.60) MAPTKDM4ETDP1ALDH1A1APEX1
SCHEMBL6090810 0.73 LCK (0.39) LCKTXKSYKITKPIKFYVE
SCHEMBL19490491 0.72 MAPT (0.37) MAPTKDM4ETDP1ALDH1A1APEX1
SCHEMBL763175 0.72 MAPT (0.42) MAPTKDM4ETDP1ALDH1A1APEX1
Hydrochloric Acid SCHEMBL26181295 0.70 MAPT (0.42) MAPTKDM4ETDP1ALDH1A1APEX1
Hydrochloric Acid SCHEMBL29525565 0.70 MAPT (0.42) MAPTKDM4ETDP1ALDH1A1APEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors ELI LILLY AND COMPANY (US) 2006-10-19 US disclosed
EP-1597254-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS Eli Lilly and Company (US) 2005-11-23 EP disclosed
WO-2004067529-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS ELI LILLY AND COMPANY (US) 2004-08-12 WO disclosed
WO-2004067529-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS ELI LILLY AND COMPANY (US) 2004-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors NR3C2, NR5A1, MC2R MAPT 4025/4885KDM4E 3154/4885TDP1 3945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.